Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 469601 - 469620 out of 476556 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
USA | (C10AX12) lomitapide (adm: O) | JUXTAPID 20MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ChiesiUSA,Inc. |
USA | (C10AX12) lomitapide (adm: O) | JUXTAPID 30MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ChiesiUSA,Inc. |
USA | (C10AX12) lomitapide (adm: O) | JUXTAPID 5MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ChiesiUSA,Inc. |
USA | (C10AX13) evolocumab (adm: P) | REPATHA 140MG/ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenUSA,Inc. |
USA | (C10AX13) evolocumab (adm: P) | REPATHA 140MG/ML | 2X1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenUSA,Inc. |
USA | (C10AX13) evolocumab (adm: P) | REPATHA 140MG/ML | 2X1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenUSA,Inc. |
USA | (C10AX13) evolocumab (adm: P) | REPATHA 140MG/ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenUSA,Inc. |
USA | (C10AX13) evolocumab (adm: P) | REPATHA PUSHTRONEX 420MG/3.5ML | 3.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenUSA,Inc. |
USA | (C10AX13) evolocumab (adm: P) | REPATHA PUSHTRONEX 420MG/3.5ML | 3.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenUSA,Inc. |
USA | (C10AX15) bempedoic acid (adm: O) | NEXLETOL 180MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EsperionTherapeutics |
USA | (C10AX15) bempedoic acid (adm: O) | NEXLETOL 180MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EsperionTherapeutics |
USA | (C10AX16) inclisiran (adm: P) | LEQVIO 284MG/1.5ML INJ | 1.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hypercholesterolemia;Dyslipidemias | NovartisPharmaceuticalsCorporation |
USA | (C10AX16) inclisiran (adm: P) | LEQVIO 284MG/1.5ML INJ | 1.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hypercholesterolemia;Dyslipidemias | NovartisPharmaceuticalsCorporation |
USA | (C10BA02) simvastatin and ezetimibe | VYTORIN 10-10 TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | OrganonLLC |
USA | (C10BA02) simvastatin and ezetimibe | VYTORIN 10-10 TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | OrganonLLC |
USA | (C10BA02) simvastatin and ezetimibe | VYTORIN 10-10 TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | OrganonLLC |
USA | (C10BA02) simvastatin and ezetimibe | VYTORIN 10-10 TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | OrganonLLC |
USA | (C10BA02) simvastatin and ezetimibe | VYTORIN 10-20 TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | OrganonLLC |
USA | (C10BA02) simvastatin and ezetimibe | VYTORIN 10-20 TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | OrganonLLC |
USA | (C10BA02) simvastatin and ezetimibe | VYTORIN 10-20 TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | OrganonLLC |